25 years of the antiphospholipid syndrome: Lights and shadows on the primary prophylaxis of asymptomatic patients with confirmed positivity of antiphospholipid antibodies

Internal and Emergency Medicine

Volumn 4, Issue 2, 2009, Pages 165-167

  Andreoli, Laura ^a   Tincani, Angela ^a  

^a UNIVERSITY OF BRESCIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; PHOSPHOLIPID ANTIBODY;

ANTIPHOSPHOLIPID SYNDROME; ARTICLE; BLOOD; EVIDENCE BASED MEDICINE; HUMAN; PRIMARY PREVENTION;

ANTIBODIES, ANTIPHOSPHOLIPID; ANTIPHOSPHOLIPID SYNDROME; ASPIRIN; EVIDENCE-BASED MEDICINE; HUMANS; PRIMARY PREVENTION;

EID: 62949145449     PISSN: 18280447     EISSN: 19709366     Source Type: Journal    
DOI: 10.1007/s11739-008-0222-3     Document Type: Article

References (18)

1. M Gerosa C Chighizola PL Meroni 2008 Aspirin in asymptomatic patients with confirmed positivity of antiphospholipid antibodies? Yes (in some cases) Intern Emerg Med 3 201 203
2. G Finazzi 2008 Aspirin in asymptomatic patients with confirmed positivity of antiphospholipid antibodies? No Intern Emerg Med 3 197 200
3. CJ Edwards GRV Hughes 2008 Hughes syndrome (the antiphospholipid syndrome): 25 years old Mod Rheumatol 18 119 124
4. SS Pierangeli PP Chen E Raschi 2008 Antiphospholipid antibodies and the antiphospholipid syndrome: pathogenic mechanisms Semin Thromb Hemost 34 236 250
5. S Myakis MD Lockshin T Atsumi 2006 International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS) J Thromb Haemost 4 295 306
6. Cervera R, Khamashta MA, Shoenfeld Y et al (2008) Morbidity and mortality in the antiphospholipid syndrome during a 5-year period: a multicenter prospective study of 1,000 patients. Ann Rheum Dis [Epub ahead of print]
7. D Erkan MJ Harrison R Levy 2007 Aspirin for primary thrombosis prevention in the antiphospholipid syndrome Arthritis Rheum 56 2382 2391
8. Ruffatti A, Del Ross T, Ciprian M et al (2008) Risk factors for a first thrombotic event in antiphospholipid antibody carriers. A multicenter retrospective follow-up study. Ann Rheum Dis [Epub ahead of print]
9. M Nuzzo A Ceribelli F Allegri 2007 First thrombotic event in patients with obstetric APS Clin Exp Rheum 25 25S 26S
10. D Erkan S Patel M Nuzzo 2008 Management of the controversial aspects of the antiphospholipid sindrome pregnancies: a guide for clinicians and researchers Rheumatology (Oxford) 47 iii23 iii27
11. WH Geerts D Bergqvist GF Pineo 2008 Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th edition) Chest 133 381S 453S
12. M Galli G Reber P de Moerloose PG de Groot 2008 Invitation to a debate on the serological criteria that define the antiphospholipid syndrome J Thromb Haemost 6 399 401
13. G Finazzi V Brancaccio M Moia 1996 Natural history and risk factors for thrombosis in 360 patients with antiphospholipid antibodies. A four-year prospective study from the Italian registry Am J Med 100 530 536
14. KS Ginsburg MH Liang L Newcomer 1992 Anticardiolipin antibodies and the risk for ischemic stroke and venous thrombosis Ann Intern Med 117 997 1002
15. O Vaarala M Mänttäri V Manninen 1995 Anticardiolipin antibodies and risk of myocardial infarction in a prospective cohort of middle-aged men Circulation 91 23 27
16. Y Shoenfeld PL Meroni R Cervera 2008 Antiphospholipid syndrome dilemmas still to be solved: 2008 status Ann Rheum Dis 67 438 442
17. RAS Roubey 2003 New approaches to prevention of thrombosis in the antiphospholipid syndrome: hopes, trials, and tribulations Arthritis Rheum 48 3004 3008
18. 2-glycoprotein I complexes to phospholipid bilayers Blood 112 1687 1695